Bioworld Financial Watch articles from December 2006

Bioworld Financial Watch archives from December 2006

Parkinson's, RLS spotlight: part-dopamine agonist key?(restless leg syndrome)
December 4, 2006... Parkinson's disease and restless leg syndrome (RLS) made news in two very different ways last week, as the Italian firm Newron Pharmaceuticals SpA started its second Phase III study with safinamide--just as the firm kicked off an initial public...

Collaborations between biotechnology companies and government/nonprofit institutions: Aug. 31-Nov. 29, 2006.
December 4, 2006... Collaborations Between Biotechnology Companies And Government/Nonprofit Institutions: Aug. 31-Nov. 29, 2006 Company* (Country; Symbol) University/Nonprofit@ Type Of Agreement ACE BioSciences U.S. Naval ...

BioWorld stock report for public biotechnology companies.(Statistical table)
December 4, 2006... Close Close %Change Vol Company Symbol 11/22 12/01 WK YTD (000) Aastrom Biosci ASTM 1.4 1.33 -5.00 -36.97 6423 Acadia Pharma ACAD 9.32...

Resverlogix, Isis stepping up after torcetrapib's flameout.
December 11, 2006... Trouble for Pfizer Inc. with its Phase III anti-cholesterol drug torcetrapib put would-be competitor Isis Pharmaceuticals Inc. in the catbird seat, and had industry observers chirping about even higher branches--such as the one occupied by the...

Public financing of biotechnology: November 2006.(Statistical table)
December 11, 2006... I. COMMENCED TRADING IN NOVEMBER Shares Company Date Date Shares/ Out (Symbol) (#) Filed Comm. Units (M) Price ...

Other financings of public biotechnology companies: November 2006.(Statistical table)
December 11, 2006... Company Type Of Number Of Shares, Units Or Warrants (Symbol) (#) Financing (M) Adventrx Private 14.545S Pharmaceuticals placement of Inc. (AMEX:ANX) stock Akesis ...

Venture capital and other investments in private biotechnology companies: November 2006.(Table)
December 11, 2006... FINANCING OF PRIVATE BIOTECHNOLOGY COMPANIES: $692.42M Company Location Date Aegera Montreal 11/20/06 Therapeutics Inc. Alba Baltimore 11/27/06...

Milestone payments from corporate partners: November 2006.
December 11, 2006... These graphs compare the performance of the biotech stocks for all of 2006 using two different measures. The BioWorld Stock Indicator measures the average percent change year to date in the 262 U.S. biotech and biotech-related stocks that...

Bioworld stock report for public biotechnology companies.(Statistical table)
December 11, 2006... Close Close %Change Company Symbol 12/01 12/08 WK YTD Vol (000) Aastrom Biosci ASTM 1.33 1.42 6.77 -32.70 7174 Acadia Pharma ACAD 9.29 8.96...

Renal cell carcinoma high on Biotech's 'to-beat' list.(Idera Pharmaceuticals Inc. signed A DEAL with Merck & Co. Inc.)
December 18, 2006... Last week's potential $455 million deal that Idera Pharmaceuticals Inc. signed with Merck & Co. Inc. was more about vaccines than anything else, but the agreement also turned investor eyes to an important oncology indication: renal cell...

Biotechnology company deals with other biotechnology companies: Oct. 19-Dec. 13, 2006.
December 18, 2006... Company* Company* (Country; Symbol) (Country; Symbol) Type/Product Area AC Immune Ltd.* Genentech Inc. Deal to develop anti-beta- (Switzerland) (NYSE:DNA) amyloid antibodies for treating ...

Biotechnology company deals with miscellaneous companies: Oct. 19-Dec. 13, 2006.(Brief article)
December 18, 2006... Company* (Country; Symbol) Company Type/Product Area Codexis Inc.* Shell Oil Collaboration to explore enhanced Products US methods of converting biomass to ...

Manufacturing, marketing and distribution agreements between biotech companies: Oct. 19-Dec. 13, 2006.(Brief article)
December 18, 2006... Company* (Country; Company* (Country; Symbol) Symbol) Product Avecia Biotechnology Illumigen Biosciences Deal for the process Inc.* Inc.* development and ...

Biotech-biotech collaborations: modified and terminated agreements: Oct. 19-Dec. 13, 2006.
December 18, 2006... I. MODIFIED AGREEMENTS Company* (Country; Company* (Country; Symbol) Symbol) Product Maxygen Inc. (MAXY) Codexis Inc.* Codexis got additional rights to...

BioWorld stock report for public biotechnology companies.(Statistical table)
December 18, 2006... Close Close Change Vol Company Symbol 12/08 12/15 WK YTD (000) Aastrom Biosci ASTM 1.42 1.31 -7.75 -37.91 6092 Acadia Pharma ACAD 8.96...

GSK's antibody push helps Genmab to landmark deal.
December 25, 2006... Takeover talks rumbled, but nobody could fully explain the mystery uptick in Genmab A/S' stock price at the start of December--and most industry observers had quit trying by last week, when the Danish firm made public its potential DKK12...

Clinical trials update: November 2006.(Table)
December 25, 2006... Company* (Country; Symbol) Product Description Indication AUTOIMMUNE Alba AT-1001 Oral zonulin Celiac disease Therapeutics receptor antagonist Corp.* BioMS...

Non-U.S. clinical trials and regulatory actions: November 2006.(Table)
December 25, 2006... Company* (Country; Symbol) Product Description Indication AUTOIMMUNE Abbott Humira Adalimumab Ankylosing Laboratories spondylitis...

FDA submissions, approvals and other actions: November 2006.(Table)
December 25, 2006... Company* (Country; Symbol) Product Description Indication AUTOIMMUNE Abbott Humira Adalimumab Psoriatic Laboratories (FDA-approved) arthritis...

BioWorld stock report for public biotechnology companies.(Statistical table)
December 25, 2006... Close Close %Change Vol Company Symbol 12/15 12/22 WK YTD (000) Aastrom Biosci ASTM 1.31 1.23 -6.11 -41.71 3918 Acadia Pharma ACAD 9.16...